Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Particle Accelerators × Head & Neck × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1 Gynecologic 1 Gastrointestinal 1

Conditions

Head and Neck Neoplasms 1

Interventions

Cisplatin 206 Radiotherapy 142 Cetuximab 133 Docetaxel 84 Fluorouracil 83 pembrolizumab 74 Radiotherapy, Intensity-Modulated 67 Carboplatin 64 Paclitaxel 61 Nivolumab 49 Gemcitabine 27 Erlotinib Hydrochloride 27 durvalumab 25 Surveys and Questionnaires 25 Radiation 23 Drug Therapy 22 Gefitinib 20 Immunohistochemistry 19 Capecitabine 18 Bevacizumab 17 tremelimumab 16 Ipilimumab 16 Surgical Procedures, Operative 14 Sorafenib 14 Pemetrexed 14 Magnetic Resonance Spectroscopy 14 Afatinib 14 lenvatinib 13 Gene Expression Profiling 13 Cyclophosphamide 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04379505 2023-12-08

PEAQ-RT

Washington University School of Medicine

Phase NA Completed

Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡